RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 9.8765

Change

+0.10 (+0.99)%

Market Cap

N/A

Volume

2.60K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

+0.10 (+0.92%)

USD 1.10B
SOXS Direxion Daily Semiconductor B..

+0.21 (+1.05%)

USD 0.95B
PSQ ProShares Short QQQ

+0.45 (+1.14%)

USD 0.60B
SPXU ProShares UltraPro Short S&P50..

+0.65 (+2.66%)

USD 0.55B
SDOW ProShares UltraPro Short Dow30

+0.36 (+2.75%)

USD 0.32B
YANG Direxion Daily FTSE China Bear..

-0.37 (-13.41%)

USD 0.28B
RWM ProShares Short Russell2000

+0.16 (+0.84%)

USD 0.17B
DOG ProShares Short Dow30

+0.24 (+0.90%)

USD 0.16B
SPDN Direxion Daily S&P 500® Bear ..

+0.11 (+0.98%)

USD 0.16B
DUST Direxion Daily Gold Miners Ind..

+0.13 (+2.40%)

USD 0.12B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2,549.19% 42% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,549.19% 42% F 99% N/A
Trailing 12 Months  
Capital Gain 2,323.68% 40% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,323.68% 40% F 98% N/A
Trailing 5 Years  
Capital Gain 581.73% 46% F 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 581.73% 46% F 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike